TrialSignal
Clinical trial intelligence report
Quit4Life+: Adapting and Evaluating a Phone-Based Tobacco Use Cessation Program for People Living With HIV in Uganda and Zambia (Quit4Life+ )
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 20, 2026
NCT ID
NCT05487807
Status
RECRUITING
Phase
Phase 1
Sponsor
University of Southern California
Executive brief
Investment-Ready Snapshot
The Quit4Life+ trial aims to evaluate a phone-based tobacco cessation program specifically designed for individuals living with HIV in Uganda and Zambia. This intervention will be compared against standard care and nicotine replacement therapy, providing insights into its efficacy and feasibility in low-resource settings. The study is expected to inform cost-effective strategies for tobacco cessation among HIV patients, potentially leading to significant health improvements.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT05487807
Indication
Nicotine Dependence
Modality
small molecule
Target
Tobacco use cessation in people living with HIV
Intervention
Nicotine patch, text messaging
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.